SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
October 7, 2005
------------------------------------------------
Date of Report (Date of earliest event reported)
NANOPIERCE TECHNOLOGIES, INC.
------------------------------------------------------
(Exact name of Registrant as specified in its charter)
Nevada 33-19598-D 84-0992908
----------------------------------------------------------------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification Number)
370 17th Street, Suite 3640
Denver, Colorado 80202
-------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(303) 592-1010
------------------------------------------------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre- commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
SECTION 7 - REGULATION FD
ITEM 7.01 REGULATION FD DISCLOSURE.
Shareholder Letter
The information in this Item 7.01 of this Current Report is furnished pursuant
to Item 7.01 and shall not be deemed "filed" for any purpose, including for the
purposes of Section 18 of the Exchange Act, or otherwise subject to the
liabilities of that Section. The information in this Current Report on Form 8-K
shall not be deemed incorporated by reference into any filing under the
Securities Act or the Exchange Act regardless of any general incorporation
language in such filing.
On October 7, 2005, NanoPierce Technologies, Inc. posted a Letter to the
Shareholders of NanoPierce Technologies, Inc. discussing the BioAgra, LLC Joint
Venture on its corporate website. The text of the letter is attached hereto as
Exhibit 99.1.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits: The following exhibits are hereby filed as part of
this report on Form 8-K. Exhibit numbers correspond to the
numbers in the exhibit table of Item 601 of Regulation S-B.
EXHIBIT NO. DESCRIPTION
99.1* Form of Shareholder Letter, dated as of October 7, 2005 discussing
BioAgra, LLC joint venture.
________________
*Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 7, 2005 NANOPIERCE TECHNOLOGIES, INC.
/s/Kristi J. Kampmann
-----------------------------
Kristi J. Kampmann,
Chief Financial Officer